PubMed · 15511467
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Donald Low. 2004. Invited commentary.. https://doi.org/10.1016/j.athoracsur.2004.05.041
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A new exponentially weighted moving average (EWMA) control chart well suited for 'online' routine surveillance of medical procedures is introduced. The chart is based on inter-event counts for failures recorded when the failures occur. The method can be used for many types of hospital procedures and activities, such as problems or errors in surgery, hospital-acquired infections, erroneous handling or prescription of medicine, deviations from scheduled treatments causing inconveniences for patients. The construction, the use and the effectiveness of the control chart are demonstrated by two well-known examples about wound infection in orthopaedic surgery and neonatal arterial switch surgery. The method is easy to implement and apply, it illustrates, estimates and tests the current failure rate. Comparisons with two examples from the literature indicate that its ability to quickly detect an increased failure rate is comparable to that of other well-established methods.
The purpose of the present study was to determine the incidence, size, location, course, and content of the foramina and bony canals located on the lingual side of the mandibular midline. Fifty dry human mandibles were morphometrically analyzed by measuring the distances of these midline foramina from the mandibular base and the dimensions of these foramina and their bony canals. In addition, macro- and microanatomical dissection was performed on 12 intact cadaver mandibles. The macroanatomic midline foramina were classified into superior and inferior genial spinal foramina according to their vertical location with respect to the genial spines. This study showed that out of 50 dry mandibles, 49 (98%) had at least one midline lingual foramen; only one lacked a true midline foramen. Evaluation of the microanatomical dissections indicated a clear neurovascular bundle in both superior and inferior genial spinal foramina and canals. For the superior canal, the content was found to derive from the lingual artery and the lingual nerve. For the inferior canal, however, the arterial origin was submental and/or sublingual, while the innervation derived from a branch of the mylohyoid nerve. In conclusion, different kinds of lingual foramina have been identified according to their location. The superior and inferior genial spinal foramina have different neurovascular contents, determined by their anatomical location above or below the genial spines.
Platelet-derived growth factor (PDGF) has been implicated in smooth muscle cell (SMC) proliferation, a key event in the development of myointimal hyperplasia in vascular grafts. Recent evidence suggests that the PDGF receptor (PDGFR) tyrosine kinase inhibitor, imatinib, can prevent arterial proliferative diseases. Because hyperplasia is far more common at the venous anastomosis than the arterial anastomosis in vascular grafts, we investigated whether imatinib also inhibited venous SMC (VSMC) proliferation, and examined possible differences in its mechanism of action between VSMC and arterial SMC (ASMC). Human ASMC and VSMC were stimulated with PDGF-AB, in the presence or absence of imatinib (0.1-10 microM). Proliferation was assayed using the 5-bromo-2'-deoxyuridine (BrdU) incorporation assay, while PDGFR, Akt and ERK1/2-mitogen activated protein kinase (MAPK) signaling pathways were investigated by immunoblotting. The proliferative response to PDGF at 50 and 100 ng/ml was 32 and 43% greater, respectively, in VSMC than in ASMC. Similarly, PDGF-stimulated proliferation was more sensitive to inhibition by imatinib in VSMC than ASMC (IC(50) = 0.05 microM vs. 0.4 microM; P < 0.01). Imatinib also more effectively inhibited PDGF-induced phosphorylation of PDGFRbeta and Akt in VSMC, compared to ASMC. These data highlight inherent pharmacodynamic differences between VSMC and ASMC in receptor and cell signaling functions and suggest that imatinib therapy may be useful for the prevention of venous stenosis in vascular grafts.